The genetic sequence, origin, and diagnosis of SARS-CoV-2.

Link to article at PubMed

Icon for Springer Related Articles

The genetic sequence, origin, and diagnosis of SARS-CoV-2.

Eur J Clin Microbiol Infect Dis. 2020 Apr 24;:

Authors: Wang H, Li X, Li T, Zhang S, Wang L, Wu X, Liu J

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a new infectious disease that first emerged in Hubei province, China, in December 2019, which was found to be associated with a large seafood and animal market in Wuhan. Airway epithelial cells from infected patients were used to isolate a novel coronavirus, named the SARS-CoV-2, on January 12, 2020, which is the seventh member of the coronavirus family to infect humans. Phylogenetic analysis of full-length genome sequences obtained from infected patients showed that SARS-CoV-2 is similar to severe acute respiratory syndrome coronavirus (SARS-CoV) and uses the same cell entry receptor, angiotensin-converting enzyme 2 (ACE2), as SARS-CoV. The possible person-to-person disease rapidly spread to many provinces in China as well as other countries. Without a therapeutic vaccine or specific antiviral drugs, early detection and isolation become essential against novel Coronavirus. In this review, we introduced current diagnostic methods and criteria for the SARS-CoV-2 in China and discuss the advantages and limitations of the current diagnostic methods, including chest imaging and laboratory detection.

PMID: 32333222 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published.